{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:40:09Z","timestamp":1649191209762},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00262-012-1229-1","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T11:22:17Z","timestamp":1332501737000},"page":"1819-1832","source":"Crossref","is-referenced-by-count":1,"title":["Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma"],"prefix":"10.1007","volume":"61","author":[{"given":"Corey M.","family":"Munger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganapati V.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantaram S.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"1229_CR1","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","volume":"87","author":"DD Weisenburger","year":"1996","unstructured":"Weisenburger DD, Armitage JO (1996) Mantle cell lymphoma: an entity comes of age. Blood 87:4483\u20134494","journal-title":"Blood"},{"key":"1229_CR2","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES (1999) Mantle-cell lymphoma. Semin Hematol 36:115\u2013127","journal-title":"Semin Hematol"},{"key":"1229_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/hupa.2002.30221","volume":"33","author":"SH Swerdlow","year":"2002","unstructured":"Swerdlow SH, Williams ME (2002) From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 33:7\u201320","journal-title":"Hum Pathol"},{"key":"1229_CR4","doi-asserted-by":"crossref","unstructured":"Dreyling M, Hiddemann W (2009) European MCL Network. Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology Am Soc Hematol Educ Program 2009(1):542\u2013551","DOI":"10.1182\/asheducation-2009.1.542"},{"key":"1229_CR5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.sla.0000247058.43243.7b","volume":"244","author":"M Koch","year":"2006","unstructured":"Koch M, Beckhove P, Op den Winkel J et al (2006) Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg 244:986\u2013992 discussion 992-3","journal-title":"Ann Surg"},{"key":"1229_CR6","first-page":"10","volume":"7","author":"CI Liakou","year":"2007","unstructured":"Liakou CI, Narayanan S, Ng Tang D, Logothetis CJ, Sharma P (2007) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. Cancer Immun 7:10","journal-title":"Cancer Immun"},{"key":"1229_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/labinvest.3700389","volume":"86","author":"P Yu","year":"2006","unstructured":"Yu P, Fu YX (2006) Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 86:231\u2013245","journal-title":"Lab Invest"},{"key":"1229_CR8","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1200\/JCO.2006.07.1100","volume":"24","author":"A Mackensen","year":"2006","unstructured":"Mackensen A, Meidenbauer N, Vogl S, Laumer M, Berger J, Andreesen R (2006) Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 24:5060\u20135069","journal-title":"J Clin Oncol"},{"key":"1229_CR9","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4049\/jimmunol.170.4.2161","volume":"170","author":"N Meidenbauer","year":"2003","unstructured":"Meidenbauer N, Marienhagen J, Laumer M et al (2003) Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J Immunol 170:2161\u20132169","journal-title":"J Immunol"},{"key":"1229_CR10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3324\/haematol.10433","volume":"92","author":"E Marijt","year":"2007","unstructured":"Marijt E, Wafelman A, van der Hoorn M et al (2007) Phase I\/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation. Haematologica 92:72\u201380","journal-title":"Haematologica"},{"key":"1229_CR11","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2007-12-128843","volume":"112","author":"BG Till","year":"2008","unstructured":"Till BG, Jensen MC, Wang J et al (2008) Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood 112:2261\u20132271","journal-title":"Blood"},{"key":"1229_CR12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/bmt.2008.426","volume":"43","author":"M Kapp","year":"2009","unstructured":"Kapp M, Stevanovic S, Fick K et al (2009) CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT. Bone Marrow Transplant 43:399\u2013410","journal-title":"Bone Marrow Transplant"},{"key":"1229_CR13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07886.x","volume":"147","author":"O Ringden","year":"2009","unstructured":"Ringden O, Karlsson H, Olsson R, Omazic B, Uhlin M (2009) The allogeneic graft-versus-cancer effect. Br J Haematol 147:614\u2013633","journal-title":"Br J Haematol"},{"key":"1229_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coi.2010.01.002","volume":"22","author":"NC Robson","year":"2010","unstructured":"Robson NC, Hoves S, Maraskovsky E, Schnurr M (2010) Presentation of tumour antigens by dendritic cells and challenges faced. Curr Opin Immunol 22:137\u2013144","journal-title":"Curr Opin Immunol"},{"key":"1229_CR15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0925-4439(99)00108-8","volume":"1500","author":"TH Scott-Taylor","year":"2000","unstructured":"Scott-Taylor TH, Pettengell R, Clarke I et al (2000) Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. Biochim Biophys Acta 1500:265\u2013279","journal-title":"Biochim Biophys Acta"},{"key":"1229_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.leukres.2005.08.016","volume":"30","author":"CA Tucker","year":"2006","unstructured":"Tucker CA, Bebb G, Klasa RJ et al (2006) Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of mantle cell lymphoma. Leuk Res 30:449\u2013457","journal-title":"Leuk Res"},{"key":"1229_CR17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood-2002-04-1273","volume":"101","author":"C Milazzo","year":"2003","unstructured":"Milazzo C, Reichardt VL, Muller MR, Grunebach F, Brossart P (2003) Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA. Blood 101:977\u2013982","journal-title":"Blood"},{"key":"1229_CR18","first-page":"1337","volume":"28","author":"CM Munger","year":"2006","unstructured":"Munger CM, Vose JM, Joshi SS (2006) Dendritic cell-based therapy for mantle cell lymphoma. Int J Oncol 28:1337\u20131343","journal-title":"Int J Oncol"},{"key":"1229_CR19","doi-asserted-by":"crossref","unstructured":"Yu Z, Ma B, Zhou Y, et al (2007) Allogeneic tumor vaccine produced by electrofusion between osteosarcoma cell line and dendritic cells in the induction of antitumor immunity. Cancer Invest 25:535\u2013541","DOI":"10.1080\/07357900701508918"},{"key":"1229_CR20","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/j.vaccine.2006.12.035","volume":"25","author":"S Koido","year":"2007","unstructured":"Koido S, Tanaka Y, Tajiri H, Gong J (2007) Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. Vaccine 25:2610\u20132619","journal-title":"Vaccine"},{"key":"1229_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","volume":"222","author":"R Kennedy","year":"2008","unstructured":"Kennedy R, Celis E (2008) Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol Rev 222:129\u2013144","journal-title":"Immunol Rev"},{"key":"1229_CR22","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1158\/0008-5472.CAN-06-2283","volume":"67","author":"H Singh","year":"2007","unstructured":"Singh H, Serrano LM, Pfeiffer T et al (2007) Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy. Cancer Res 67:2872\u20132880","journal-title":"Cancer Res"},{"key":"1229_CR23","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","volume":"66","author":"CM Kowolik","year":"2006","unstructured":"Kowolik CM, Topp MS, Gonzalez S et al (2006) CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. Cancer Res 66:10995\u201311004","journal-title":"Cancer Res"},{"key":"1229_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2567.2003.01596.x","volume":"108","author":"H Winter","year":"2003","unstructured":"Winter H, Hu HM, Poehlein CH et al (2003) Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies. Immunology 108:409\u2013419","journal-title":"Immunology"},{"key":"1229_CR25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1349-7006.2006.00231.x","volume":"97","author":"T Kondo","year":"2006","unstructured":"Kondo T, Nakazawa H, Ito F et al (2006) Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response. Cancer Sci 97:780\u2013786","journal-title":"Cancer Sci"},{"key":"1229_CR26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1172\/JCI30973","volume":"117","author":"C Anasetti","year":"2007","unstructured":"Anasetti C, Mule JJ (2007) To ablate or not to ablate? HSCs in the T cell driver\u2019s seat. J Clin Invest 117:306\u2013310","journal-title":"J Clin Invest"},{"key":"1229_CR27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1084\/jem.20050732","volume":"202","author":"L Gattinoni","year":"2005","unstructured":"Gattinoni L, Finkelstein SE, Klebanoff CA et al (2005) Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med 202:907\u2013912","journal-title":"J Exp Med"},{"key":"1229_CR28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncponc0666","volume":"3","author":"P Muranski","year":"2006","unstructured":"Muranski P, Boni A, Wrzesinski C et al (2006) Increased intensity lymphodepletion and adoptive immunotherapy\u2013how far can we go? Nat Clin Pract Oncol 3:668\u2013681","journal-title":"Nat Clin Pract Oncol"},{"key":"1229_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrc2804","volume":"10","author":"RR Jenq","year":"2010","unstructured":"Jenq RR, van den Brink MR (2010) Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer 10:213\u2013221","journal-title":"Nat Rev Cancer"},{"key":"1229_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI0216166","volume":"110","author":"GN Maine","year":"2002","unstructured":"Maine GN, Mule JJ (2002) Making room for T cells. J Clin Invest 110:157\u2013159","journal-title":"J Clin Invest"},{"key":"1229_CR31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1471-4906(01)02028-2","volume":"22","author":"TJ Fry","year":"2001","unstructured":"Fry TJ, Mackall CL (2001) Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 22:564\u2013571","journal-title":"Trends Immunol"},{"key":"1229_CR32","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","volume":"23","author":"ME Dudley","year":"2005","unstructured":"Dudley ME, Wunderlich JR, Yang JC et al (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23:2346\u20132357","journal-title":"J Clin Oncol"},{"key":"1229_CR33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.022634999","volume":"99","author":"W Asavaroengchai","year":"2002","unstructured":"Asavaroengchai W, Kotera Y, Mule JJ (2002) Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery. Proc Natl Acad Sci USA 99:931\u2013936","journal-title":"Proc Natl Acad Sci USA"},{"key":"1229_CR34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI30414","volume":"117","author":"C Wrzesinski","year":"2007","unstructured":"Wrzesinski C, Paulos CM, Gattinoni L et al (2007) Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J Clin Invest 117:492\u2013501","journal-title":"J Clin Invest"},{"key":"1229_CR35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)63140-9","volume":"164","author":"A Martinez","year":"2004","unstructured":"Martinez A, Bellosillo B, Bosch F et al (2004) Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am J Pathol 164:501\u2013510","journal-title":"Am J Pathol"},{"key":"1229_CR36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","volume":"127","author":"HM Amin","year":"2003","unstructured":"Amin HM, McDonnell TJ, Medeiros LJ et al (2003) Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med 127:424\u2013431","journal-title":"Arch Pathol Lab Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1229-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-012-1229-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1229-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T16:55:05Z","timestamp":1641488105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1229-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1229-1","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]}}}